Clinical Review Managing hepatitis C virus infection BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b2366 (Published 26 June 2009) Cite this as: BMJ 2009;338:b2366 Article Related content Metrics Responses Peer review Data supplement Web extra Extra references supplied by the author Files in this Data Supplement: Data Supplement Related articles Practice Protease inhibitors for treatment of genotype 1 hepatitis C virus infection Published: 10 November 2011; BMJ 343 doi:10.1136/bmj.d6972 See more Cholera: Malawi is in grip of its deadliest outbreak BMJ February 09, 2023, 380 p328; DOI: https://doi.org/10.1136/bmj.p328 Emergency care is in “dire” situation after loss of NHS beds, says royal college BMJ May 31, 2022, 377 o1376; DOI: https://doi.org/10.1136/bmj.o1376 GP efforts to cut antibiotic use failed to curb spread of drug resistant E coli, evaluation finds BMJ August 05, 2021, 374 n1953; DOI: https://doi.org/10.1136/bmj.n1953 Check covid status when planning emergency bowel surgery, doctors are told BMJ March 11, 2021, 372 n695; DOI: https://doi.org/10.1136/bmj.n695 Capsule endoscopies will be trialled in England BMJ March 11, 2021, 372 n692; DOI: https://doi.org/10.1136/bmj.n692 Cited by... Protease inhibitors for treatment of genotype 1 hepatitis C virus infectionFulltext PDF
